Cargando…

A walk through tau therapeutic strategies

Tau neuronal and glial pathologies drive the clinical presentation of Alzheimer’s disease and related human tauopathies. There is a growing body of evidence indicating that pathological tau species can travel from cell to cell and spread the pathology through the brain. Throughout the last decade, p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jadhav, Santosh, Avila, Jesus, Schöll, Michael, Kovacs, Gabor G., Kövari, Enikö, Skrabana, Rostislav, Evans, Lewis D, Kontsekova, Eva, Malawska, Barbara, de Silva, Rohan, Buee, Luc, Zilka, Norbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376692/ https://www.ncbi.nlm.nih.gov/pubmed/30767766 http://dx.doi.org/10.1186/s40478-019-0664-z

Ejemplares similares

Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer’s disease
por: Kontsekova, Eva, et al.
Publicado: (2014)

Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead
por: Novak, Petr, et al.
Publicado: (2018)

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
por: Kontsekova, Eva, et al.
Publicado: (2014)

Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans
por: Weisová, Petronela, et al.
Publicado: (2019)

Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation
por: Zilkova, Monika, et al.
Publicado: (2020)

NMR Studies of Tau Protein in Tauopathies
por: Kitoka, Kristine, et al.
Publicado: (2021)

Truncated tau deregulates synaptic markers in rat model for human tauopathy
por: Jadhav, Santosh, et al.
Publicado: (2015)

Tau-mediated synaptic damage in Alzheimer’s disease
por: Jadhav, Santosh, et al.
Publicado: (2015)

EuroTau: towing scientists to tau without tautology
por: Mudher, Amrit, et al.
Publicado: (2017)

Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
por: Smolek, Tomas, et al.
Publicado: (2019)

Corrigendum: Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
por: Smolek, Tomas, et al.
Publicado: (2020)

Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways
por: Zilka, Norbert, et al.
Publicado: (2012)

Enriched environment ameliorates propagation of tau pathology and improves cognition in rat model of tauopathy
por: Mate, Veronika, et al.
Publicado: (2022)

MicroRNAs and the Regulation of Tau Metabolism
por: Hébert, Sébastien S., et al.
Publicado: (2012)

Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias
por: Hanes, Jozef, et al.
Publicado: (2020)

Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
por: Laurent, Cyril, et al.
Publicado: (2018)

Structure and Functions of Microtubule Associated Proteins Tau and MAP2c: Similarities and Differences
por: Melková, Kateřina, et al.
Publicado: (2019)

FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease
por: Novak, Petr, et al.
Publicado: (2018)

Astroglia and Tau: New Perspectives
por: Kovacs, Gabor G.
Publicado: (2020)

Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey
por: da Costa, Paulo J., et al.
Publicado: (2022)

AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo
por: Domise, Manon, et al.
Publicado: (2016)

Atypical, non-standard functions of the microtubule associated Tau protein
por: Sotiropoulos, Ioannis, et al.
Publicado: (2017)

Tau- but not Aß -pathology enhances NMDAR-dependent depotentiation in AD-mouse models
por: Faldini, Enrico, et al.
Publicado: (2019)

Microglia display modest phagocytic capacity for extracellular tau oligomers
por: Majerova, Petra, et al.
Publicado: (2014)

Astrocytes Derived from Familial and Sporadic Alzheimer’s Disease iPSCs Show Altered Calcium Signaling and Respond Differently to Misfolded Protein Tau
por: Brezovakova, Veronika, et al.
Publicado: (2022)

The Tau Code
por: Avila, Jesús
Publicado: (2009)

Cancer Cells Upregulate Tau to Gain Resistance to DNA Damaging Agents
por: Rico, Thomas, et al.
Publicado: (2022)

Two-Dimensional Electrophoresis of Tau Mutants Reveals Specific Phosphorylation Pattern Likely Linked to Early Tau Conformational Changes
por: Bretteville, Alexis, et al.
Publicado: (2009)

Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies
por: Tardivel, Meryem, et al.
Publicado: (2016)

Intracellular and Extracellular Tau
por: Avila, Jesús
Publicado: (2010)

Tau Stabilizes Chromatin Compaction
por: Rico, Thomas, et al.
Publicado: (2021)

Different tau species lead to heterogeneous tau pathology propagation and misfolding
por: Dujardin, Simon, et al.
Publicado: (2018)

Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease
por: Stozicka, Zuzana, et al.
Publicado: (2010)

Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology
por: Sierksma, Annerieke, et al.
Publicado: (2020)

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies
por: Šimić, Goran, et al.
Publicado: (2016)

What is the evidence that tau pathology spreads through prion-like propagation?
por: Mudher, Amrit, et al.
Publicado: (2017)

Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody
por: Albert, Marie, et al.
Publicado: (2019)

Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials
por: Basheer, Neha, et al.
Publicado: (2023)

From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy
por: Colin, Morvane, et al.
Publicado: (2019)

Time to Kill and Time to Heal: The Multifaceted Role of Lactoferrin and Lactoferricin in Host Defense
por: Ohradanova-Repic, Anna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dh9fhq34s851osh76gatkkgnl2